Refractory Multiple Myeloma

Relapsed Refractory Multiple Myeloma | Current Treatment Options | Options on the Horizon

Multiple Myeloma Research Foundation - MMRF

Relapsed Refractory Multiple Myeloma - Krina Patel, MD, MSc | RT Irvine, CA Nov 5, 2022

HealthTree Foundation for Multiple Myeloma

Treatment Decisions in Relapsed/Refractory Multiple Myeloma

Challenges in treating patients with triple-class refractory multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

New treatment for patients with relapsed/refractory multiple myeloma

Winship Cancer Institute of Emory University

Multiple Myeloma: Combination Therapy for Relapsed/Refractory Patients

Treatment for Relapsed and Refractory Multiple Myeloma

Cancer Support Community

Teclistamab in relapsed/refractory multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Relapsed/Refractory Multiple Myeloma Treatment Algorithm with Dr. Samer Al’Hadidi

OncBrothers: Practice-Changing Cancer Discussions

Management of Relapsed/Refractory Multiple Myeloma

How I Treat Relapsed/Refractory Multiple Myeloma - Kenneth Anderson, MD

American Society of Hematology

Relapsed/Refractory Multiple Myeloma: Optimal Therapy

Treating Double-Refractory Multiple Myeloma

Treatment Options in Relapsed/Refractory Multiple Myeloma

Recent drug approvals for the treatment of relapsed/refractory multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Promising novel agents for relapsed/refractory multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Emerging Therapies for Relapsed/Refractory Multiple Myeloma

Venetoclax monotherapy for relapsed/refractory multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

A review of the treatment evolution in relapsed/refractory multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Defining Relapsed and Refractory Myeloma; what's the difference?

HealthTree University for Multiple Myeloma